Current through Register Vol. 50, No. 9, September 20, 2024
Section XLV-3923 - Approval of Schools and CollegesA. A school, college, university or institution shall be concurrently considered approved by the board for purposes of qualification under this Chapter provided it: 1. is accredited by one of the six regional bodies recognized by the United States Department of Educations' Council on Postsecondary Accreditation;2. has achieved the highest level of accreditation or approval awarded by statutory authorities of the state in which the school or college is located;3. offers a full-time post-doctoral master's program in clinical psychopharmacology that: a. includes curriculum instruction in each of the following areas: i. anatomy and physiology;iii. neurosciences to include neuroanatomy, neuropathology, neurophysiology, neurochemistry and neuroimaging;vi. clinical medicine/pathophysiology; andvii. health assessment, including relevant physical and laboratory assessment; andb. provides opportunity to review, present and discuss each of the following: i. case examples representing a broad range of clinical psychopathologies;ii. medical conditions presenting as psychiatric illness;iii. treatment complexities, including complicating medical conditions, diagnostic questions, choice of medications, and untoward side effects;iv. compliance problems; andv. alternative treatments and treatment failures.B. Board approval of a school, college, university or institution shall be deemed to be effective as to an applicant if such school, college, university or institution was approved as of the date on which the applicant's post-doctoral master's degree in clinical psychopharmacology was awarded.C. Subject to Section 3925 of these rules, a school, college, university or institution accepted by the LSBPE for MP prescriptive authority on or before January 1, 2010, shall be considered approved by the board for purposes of qualification under this Chapter.D. For the purposes of this Chapter, equivalent training to the post-doctoral master's degree provided in R.S. 37:1360.55 B.(2) is defined as the successful completion of the Department of Defense Psychopharmacology Demonstration Project (DOD-PDP), or a similar program developed and operated under the auspices of any branch of the United States armed services and approved by the board.La. Admin. Code tit. 46, § XLV-3923
Promulgated by the Department of Health and Hospitals, Board of Medical Examiners, LR 37:891 (March 2011).AUTHORITY NOTE: Promulgated in accordance with R.S. 37:1270, 37:1360.51-1360.72.